Bayer

BAYN · Xetra · EUR

€44.94−1.01%−€0.46

Close · October 2, 2026

At a glance

Revenue growth: −2.21%; 2025 vs 2024
Net margin: -7.9%; 2024: -5.5%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Balance sheet · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total assets	104,541	110,850	116,259	124,877	120,241	116,804	126,174	126,732	75,087	82,238
Current assets	32,911	34,444	37,556	37,760	32,578	35,675	32,439	31,065	30,073	30,447
Cash and equivalents	6,671	6,191	5,907	5,171	4,564	4,191	3,185	4,052	7,581	1,899
Short-term investments	36.0	75.0	755	32.0	669	1,311	928	285	1,517	3,525
Receivables	12,170	12,188	12,522	13,450	12,980	12,157	14,851	14,137	11,643	15,584
Inventory	12,378	13,467	13,947	13,636	11,314	10,961	10,650	11,132	6,550	8,408
Net property, plant and equipment	12,649	13,456	13,321	13,674	12,688	11,723	12,479	12,943	7,633	13,114
Goodwill	28,061	30,016	32,299	39,648	40,106	36,418	39,312	38,442	14,751	16,312
Other intangible assets	20,622	22,112	19,822	20,419	21,958	21,070	29,218	31,489	10,747	12,915
Long-term investments	2,670	3,022	3,060	2,895	2,612	1,998	1,984	2,680	5,275	1,753
Current liabilities	32,585	28,952	29,457	35,084	29,403	36,768	23,215	23,125	13,593	18,537
Accounts payable	7,081	7,518	7,456	7,545	6,792	5,678	6,426	6,038	5,129	6,410
Long-term debt	30,806	34,559	37,232	32,839	35,552	32,270	35,960	37,363	12,277	15,803
Total debt	37,579	40,811	45,006	41,652	40,872	41,770	39,094	41,394	14,418	19,581
Total liabilities	78,478	78,805	83,181	85,951	87,073	86,129	78,741	80,584	38,226	50,341
Total equity (incl. minority)	26,063	32,045	33,078	38,926	33,168	30,675	47,433	46,148	36,861	31,897
Retained earnings	6,726	9,867	12,175	17,233	13,345	13,057	26,151	25,734	26,851	18,393
Minority interest	116	137	151	153	148	152	180	171	60.0	1,564